Substituted fused pyrimidinones and dihydropyrimidinones
US-2015173359-A1 · Jun 25, 2015 · US
US11401271B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11401271-B2 |
| Application number | US-201816758053-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 2, 2018 |
| Priority date | Nov 3, 2017 |
| Publication date | Aug 2, 2022 |
| Grant date | Aug 2, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A fused tricyclic compound, an optical isomer, cis and trans isomers or an agromedically acceptable salt thereof, and insecticidal use thereof in agroforestry. A pyrazole-ring-contained fused heterocyclic compound, an agricultural composition, and a method of using the agricultural composition are also provided.
Opening claim text (preview).
What is claimed is: 1. A fused heterocyclic compound, and an optical isomer, cis and trans isomers or an agromedically acceptable salt thereof, the fused heterocyclic compound has a structure shown in formula (I): wherein R 11 and R 12 are each independently hydrogen, halogen, —NO 2 , —CN, —COR 17 , —CO 2 R 17 , —CONR 17 R 18 , —S(O) R 17 , —S(O) 2 R 17 , —N R 17 R 18 , —N R 17 CO R 18 , —N R 17 CON R 18 R 19 , —N R 17 CO 2 R 18 , —N R 17 S(O) 2 R 18 , alkyl, heteroalkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heterocyclyl or heteroaryl; wherein the alkyl, the alkenyl, the cycloalkyl, the cycloalkenyl, the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 , —CO 2 R 17 , —S(O) 2 R 17 , —CONR 17 R 18 , alkyl, heteroalkyl, alkenyl, cycloalkyl, cycloalkenyl and aryl; wherein the alkyl, the alkenyl, the cycloalkyl, the cycloalkenyl and the aryl are unsubstituted or substituted with one or more substituents R 10 ; R 14 and R 15 are each independently hydrogen, halogen, —CN, —OH, —N R 17 R 18 , —O R 17 , —CO R 17 , —CO 2 R 17 , —CONR 17 R 18 , —N R 17 CON R 18 , —NR 17 CON R 18 R 19 , —NR 17 CO 2 R 18 , —NR 17 S(O) 2 R 18 , —S(O)R 17 , —S(O) 2 R 17 , alkyl, heteroalkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, heterocyclyl or heteroaryl; wherein the alkyl, the alkenyl, the cycloalkyl, the cycloalkenyl, the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 , and R 14 and R 15 are not hydrogen at the same time; Y is N or CH; Z 1 , Z 2 , Z 3 and Z 4 are each independently C or N, under conditions that at most two of Z 1 to Z 4 are N, and a ring containing Z 1 to Z 4 is aromatic; R 16 represents a substituent on the ring containing Z 1 to Z 4 , one or more R 16 are provided, and each R 16 is independently hydrogen, halogen, —CN, alkyl, heteroalkyl, —CO R 17 , —CO 2 R 17 , —N R 17 R 18 , —CONR 17 R 18 , —N R 17 CO R 18 , —NR 17 CON R 18 R 19 , —NR 17 CO 2 R 18 or —NR 17 S(O) 2 R 18 ; R 17 , R 18 and R 19 are each independently hydrogen, alkyl, heteroalkyl, alkenyl, cycloalkyl, cycloalkenyl, heterocyclyl, aryl or heteroaryl; wherein the alkyl, the alkenyl, the cycloalkyl, the cycloalkenyl, the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; and R 10 is halogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, substituted or unsubstituted cycloalkyl, cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl, —CN, —NH 2 , —OR′″, —NR′″R″″, —COR′″, —CO 2 R′″, —CONR′″R″″, —NR′″COR″″, —NR′″CONR′″R″″, —NR′″CO 2 R″″, —S(O) 2 R′″ or —NR′″S(O) 2 R″″, wherein R′″ and are each independently hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl or heterocyclyl. 2. The compound according to claim 1 , or the optical isomer, the cis and trans isomers or the agromedically acceptable salt of the compound, wherein; R 11 is halogen, —CN, —COR 17 , —CONR 17 R 18 , —S(O) R 17 , —N R 17 R 18 ,—N R 17 CO R 18 , aryl, heterocyclyl or heteroaryl; wherein the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 12 is hydrogen, —COR 17 , —CONR 17 R 18 , —S(O)R 17 , —S(O) 2 R 17 , —N R 17 R 18 , —N R 17 CO R 18 , —NR 17 CONR 18 R 19 , —NR 17 CO 2 R 18 , aryl, heterocyclyl or heteroaryl; wherein the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 , alkyl, heteroalkyl or alkenyl; R 14 is halogen, —CN, —N R 17 R 18 , —O R 17 , —CO R 17 , —CO 2 R 17 , —CONR 17 R 18 , —N R 17 CO R 18 , —NR 17 CO 2 R 18 , alkyl, heteroalkyl or alkenyl; wherein the alkyl, the heteroalkyl or the alkenyl is unsubstituted or substituted with one or more substituents R 10 ; and R 15 is hydrogen, halogen, —CN, —N R 17 R 18 ,—O R 17 , —CO R 17 , —CO 2 R 17 , —CONR 17 R 18 , —N R 17 CO R 18 , —NR 17 CO 2 R 18 , alkyl, heteroalkyl or alkenyl; wherein the alkyl, the heteroalkyl or the alkenyl is unsubstituted or substituted with one or more substituents R 10 . 3. The compound according to claim 1 , or the optical isomer, the cis and trans isomers or the agromedically acceptable salt of the compound, wherein when Z 1 , Z 2 , Z 3 and Z 4 are all C, one or more R 16 are provided, and each R 16 is independently hydrogen, halogen, alkyl, heteroalkyl, alkenyl, —S(O) R 17 , —S(O) 2 R 17 , —COR 17 , —N R 17 R 18 , —CONR 17 R 18 , —N R 17 CO R 18 or —NR 17 S(O) 2 R 18 ; R 11 is halogen, —CN, —COR 17 , —CONR 17 R 18 , —S(O) R 17 , —N R 17 R 18 , —N R 17 CO R 18 , aryl, heterocyclyl or heteroaryl; wherein the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 12 is —CONR 17 R 18 , —S(O) R 17 , —S(O) 2 R 17 , —N R 17 R 18 , —N R 17 CO R 18 , —N R 17 CON R 18 R 19 , aryl, heterocyclyl or heteroaryl; wherein the aryl, the heterocyclyl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 , alkyl or alkenyl; and R 14 and R 15 are each independently halogen, —CN, —N R 17 R 18 , —O R 17 , —CO R 17 , —CO 2 R 17 , —CONR 17 R 18 , —N R 17 CO R 18 , —NR 17 CO 2 R 18 , alkyl, heteroalkyl and alkenyl; wherein the alkyl, the heteroalkyl and the alkenyl is unsubstituted or substituted with one or more substituents R 10 . 4. The compound according to claim 1 , or the optical isomer, the cis and trans isomers or the agromedically acceptable salt of the compound, wherein, R 11 is halogen, —CN, —COR 17 , —CONR 17 R 18 , —S(O) R 17 , —N R 17 R 18 or —N R 17 CO R 18 ; R 12 is —S(O) R 17 , —S(O) 2 R 17 , —N R 17 R 18 , —N R 17 CO R 18 , aryl or heteroaryl; wherein the aryl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 , alkyl or alkenyl; R 14 and R 15 are each independently halogen, —CN, —N R 17 R 18 , —O R 17 , —CO R 17 , —CO 2 R 17 , —CONR 17 R 18 , —N R 17 CO R 18 , —NR 17 CO 2 R 18 , alkyl, heteroalkyl or alkenyl; wherein the alkyl or the alkenyl is unsubstituted or substituted with one or more substituents R 10 ; and Z 1 , Z 2 , Z 3 and Z 4 are all C, one or more R 16 are provided, and each R 16 is independently halogen, alkyl, heteroalkyl, —S(O) R 17 , —S(O) 2 R 17 , —COR 17 , —N R 17 R 18 , —N R 17 CO R 18 or —NR 17 S(O) 2 R 18 . 5. The compound according to claim 4 , or the optical isomer, the cis and trans isomers or the agromedically acceptable salt of the compound, wherein, R 11 is halogen, —CN, —COR 17 or —CONR 17 R 18 ; R 12 is —s(o)R 17 , —S(O) 2 R 17 , —NR 17 COR 18 , aryl or heteroaryl; wherein the aryl or the heteroaryl is unsubstituted or substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 or alkyl; and Z 1 , Z 2 , and Z 4 are all C, one or more R 16 are provided, and each R 16 is independently halogen, heteroalkyl, —S(O)R 17 , —NR 17 R or —NR 17 COR 18 . 6. The compound according to claim 4 , or the optical isomer, the cis and trans isomers or the agromedically acceptable salt of the compound, wherein R 11 —CN or —COR 17 ; R 12 is —S(O)R 17 or aryl; wherein the aryl is substituted with one or more substituents R 10 ; R 13 is hydrogen, —COR 17 , methyl or ethyl; R 14 and R 15 are each independently halogen, —OR 17 , —COR 17 , —CO 2 R 17 , —CONR 17 R 18 , —NR 17 COR 18 , —NR 17 CO 2 R 18 , alkyl, heteroalkyl or alkenyl; wherein the alkyl or the alkenyl is unsubstituted or substituted with one
Ortho-condensed systems · CPC title
Ortho-condensed systems · CPC title
Ortho-condensed systems · CPC title
having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system · CPC title
containing the group >N—CO—N< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.